These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Post-transcriptional control of expression of sFlt-1, an endogenous inhibitor of vascular endothelial growth factor. Huckle WR; Roche RI J Cell Biochem; 2004 Sep; 93(1):120-32. PubMed ID: 15352169 [TBL] [Abstract][Full Text] [Related]
28. Cytoplasmic Polyadenylation Element Binding Protein 1 and Atherosclerosis: Prospective Target and New Insights. Zhou J; Tang CK Curr Vasc Pharmacol; 2024; 22(2):95-105. PubMed ID: 38284693 [TBL] [Abstract][Full Text] [Related]
29. CPEB3 and CPEB4 in neurons: analysis of RNA-binding specificity and translational control of AMPA receptor GluR2 mRNA. Huang YS; Kan MC; Lin CL; Richter JD EMBO J; 2006 Oct; 25(20):4865-76. PubMed ID: 17024188 [TBL] [Abstract][Full Text] [Related]
30. Cytoplasmic polyadenylation and cytoplasmic polyadenylation element-dependent mRNA regulation are involved in Xenopus retinal axon development. Lin AC; Tan CL; Lin CL; Strochlic L; Huang YS; Richter JD; Holt CE Neural Dev; 2009 Mar; 4():8. PubMed ID: 19254368 [TBL] [Abstract][Full Text] [Related]
31. Extrahepatic angiogenesis hinders recovery of portal hypertension and collaterals in rats with cirrhosis resolution. Hsu SJ; Tsai MH; Chang CC; Hsieh YH; Huang HC; Lee FY; Chuang CL; Hou MC; Lee SD Clin Sci (Lond); 2018 Mar; 132(6):669-683. PubMed ID: 29449343 [TBL] [Abstract][Full Text] [Related]
32. Activation of fractalkine/CX3CR1 by vascular endothelial cells induces angiogenesis through VEGF-A/KDR and reverses hindlimb ischaemia. Ryu J; Lee CW; Hong KH; Shin JA; Lim SH; Park CS; Shim J; Nam KB; Choi KJ; Kim YH; Han KH Cardiovasc Res; 2008 May; 78(2):333-40. PubMed ID: 18006432 [TBL] [Abstract][Full Text] [Related]
33. Insulin reverses major portal hypertension-related derangements in rats with liver cirrhosis and diabetes. Hsin IF; Huang HC; Chang CC; Hsu SJ; Lee FY; Huo TI; Chuang CL; Hou MC; Lee SD Clin Sci (Lond); 2018 Nov; 132(22):2391-2405. PubMed ID: 30348829 [TBL] [Abstract][Full Text] [Related]
34. The Impact of Spironolactone on the Severity of Portal-Systemic Collaterals and Hepatic Encephalopathy in Cirrhotic Rats. Hsu SJ; Wang SS; Huo TI; Lee FY; Huang HC; Chang CC; Hsin IF; Ho HL; Lin HC; Lee SD J Pharmacol Exp Ther; 2015 Oct; 355(1):117-24. PubMed ID: 26260462 [TBL] [Abstract][Full Text] [Related]
35. Aquaporin-1 promotes angiogenesis, fibrosis, and portal hypertension through mechanisms dependent on osmotically sensitive microRNAs. Huebert RC; Jagavelu K; Hendrickson HI; Vasdev MM; Arab JP; Splinter PL; Trussoni CE; Larusso NF; Shah VH Am J Pathol; 2011 Oct; 179(4):1851-60. PubMed ID: 21854740 [TBL] [Abstract][Full Text] [Related]
37. Knockdown of CPEB1 and CPEB4 Inhibits Scar Formation via Modulation of TAK1 and SMAD Signaling. Cui HS; Lee YR; Ro YM; Joo SY; Cho YS; Kim JB; Kim DH; Seo CH Ann Dermatol; 2023 Aug; 35(4):293-302. PubMed ID: 37550230 [TBL] [Abstract][Full Text] [Related]
38. Combined administration of propranolol + AG490 offers better effects on portal hypertensive rats with cirrhosis. Wang D; Wang Q; Yin J; Dong R; Wang Q; Du X; Lu J J Gastroenterol Hepatol; 2016 May; 31(5):1037-44. PubMed ID: 26487394 [TBL] [Abstract][Full Text] [Related]
39. Role and therapeutic potential of vascular stem/progenitor cells in pathological neovascularisation during chronic portal hypertension. Garcia-Pras E; Gallego J; Coch L; Mejias M; Fernandez-Miranda G; Pardal R; Bosch J; Mendez R; Fernandez M Gut; 2017 Jul; 66(7):1306-1320. PubMed ID: 26984852 [TBL] [Abstract][Full Text] [Related]
40. Regulation of the Expression of Cytoplasmic Polyadenylation Element Binding Proteins for the Treatment of Cancer. Chen Y; Tsai YH; Tseng SH Anticancer Res; 2016 Nov; 36(11):5673-5680. PubMed ID: 27793888 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]